HIP
EW icon

HUB Investment Partners’s Edwards Lifesciences EW Stock Holding History

HUB Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Buy
+5,000
New +$412K 0.01% 673

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HUB Investment Partners's EW Position: Q1 2026 in Review

HUB Investment Partners reduced its Edwards Lifesciences (EW) stake by 12% in Q1 2026, selling an estimated $49.4K and leaving 4,237 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #743.

HUB Investment Partners first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $412K in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • HUB Investment Partners held 4,237 shares of Edwards Lifesciences worth $339K as of Q1 2026.
  • HUB Investment Partners sold 599 Edwards Lifesciences shares in Q1 2026, an estimated $49.4K.
  • Edwards Lifesciences made up 0.01% of HUB Investment Partners's portfolio in Q1 2026, its #743 holding.
  • HUB Investment Partners first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • HUB Investment Partners's Edwards Lifesciences position peaked at $412K in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.